Literature DB >> 19700502

Synopsis and synthesis of candidate-gene association studies in chronic lymphocytic leukemia: the CUMAGAS-CLL information system.

Elias Zintzaras1, George D Kitsios.   

Abstract

A comprehensive and systematic assessment of the current status of candidate-gene association studies for chronic lymphocytic leukemia (CLL) was conducted. Data from 989 candidate-gene association studies (1992-2009) involving 905 distinct genetic variants were analyzed and cataloged in CUMAGAS-CLL, a Web-based information system which allows the retrieval and synthesis of data from candidate-gene association studies on CLL (http://biomath.med.uth.gr). Nine genetic variants (BAX (rs4645878), GSTM1 (null/present), GSTT1 (null/present), IL10 (rs1800896), LTA (rs909253), MTHFR (rs1801131), MTHFR (rs1801133), P2RX7 (rs3751143), and TNF (rs1800629)) were investigated in 4 or more studies, and their results were meta-analyzed. In individual studies, 147 variants showed a significant association with CLL risk under any genetic model. For 53 variants, the association was significant at P < 0.01 with an increased risk greater than 40%. Only 0.3% of studies had statistical power greater than 80%. In meta-analyses, none of the variants showed significant results, and heterogeneity ranged from none to high. Large and rigorous genetic studies (candidate-gene association studies and genome-wide association studies) designed to investigate epistatic and gene-environment interactions may produce more conclusive evidence about the genetic etiology of CLL. CUMAGAS-CLL would be a useful tool for current genomic epidemiology research in the field of CLL.

Entities:  

Mesh:

Year:  2009        PMID: 19700502     DOI: 10.1093/aje/kwp201

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

1.  Synopsis and data synthesis of genetic association studies in hypertension for the adrenergic receptor family genes: the CUMAGAS-HYPERT database.

Authors:  Georgios D Kitsios; Elias Zintzaras
Journal:  Am J Hypertens       Date:  2009-12-31       Impact factor: 2.689

Review 2.  Familial chronic lymphocytic leukemia.

Authors:  Lynn R Goldin; Susan L Slager; Neil E Caporaso
Journal:  Curr Opin Hematol       Date:  2010-07       Impact factor: 3.284

Review 3.  Association between the rs3751143 polymorphism of P2RX7 gene and chronic lymphocytic leukemia: A meta-analysis.

Authors:  Wen-Jun Zhang; Zheng-Ming Zhu
Journal:  Purinergic Signal       Date:  2020-10-07       Impact factor: 3.765

4.  Synopsis and meta-analysis of genetic association studies in osteoporosis for the focal adhesion family genes: the CUMAGAS-OSTEOporosis information system.

Authors:  Elias Zintzaras; Chrysoula Doxani; Theocharis Koufakis; Alkibiadis Kastanis; Paraskevi Rodopoulou; Theofilos Karachalios
Journal:  BMC Med       Date:  2011-01-26       Impact factor: 8.775

5.  Analysis of functional polymorphisms in apoptosis-related genes in primary open angle glaucoma.

Authors:  Ewald Lindner; Wilfried Glatz; Christoph Schwab; Yosuf El-Shabrawi; Georg Mossböck
Journal:  Mol Vis       Date:  2015-12-30       Impact factor: 2.367

Review 6.  Prognostic value and susceptibility of BAX rs4645878 polymorphism in cancer: A systematic review and meta-analysis.

Authors:  Ye Feng; Xianglei Chen; Yi Zheng; Qiao Liu; Haiwen Chen; Yuanhua Cai; Lixia Cao; Xiaolin Lai; Lili Pan; Yang Li; Shao-Yuan Wang
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

7.  Functional compensation of glutathione S-transferase M1 (GSTM1) null by another GST superfamily member, GSTM2.

Authors:  Pritha Bhattacharjee; Somnath Paul; Mayukh Banerjee; Deblina Patra; Priyam Banerjee; Nanda Ghoshal; Arun Bandyopadhyay; Ashok K Giri
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

8.  The single nucleotide polymorphisms of interleukin-10 are associated with the risk of leukaemia: Evidence from 18 case-control studies.

Authors:  Shupei Gao; Kun Tang; Jinqing Chen; Jianmiao Wang
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.